drugset / Trial / NCT00160290

Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures

NCT00160290

Phase 4 Terminated 97 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

To demonstrate that lactulose acts as a stool softener, relieving the pain at defecation, improving the number of defecations and regulating the colonic transit time in patients suffering of hemorrhoids or anal fissure. To compare efficacy and quality of life in patients treated either with lactulose or plantago ovate.

Timeline

Start
2002-03
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactulose Other / unclassified 15 ml
Comparator Plantago ovata Unknown 3.5 g

Indications